Immune Disorders and Its Correlation with Gut Microbiome

키워드

참고문헌 (89)

1. Sanders, M. E., "Probiotics: definition, sources, selection, and uses", Clin. Infect. Dis, 46(2), pp.S58~61 (2008)
2. Feleszko, W, "Probiotic-induced suppression of allergic sensitization and airway inflammation is associated with an increase of T regulatory-dependent mechanisms in a murine model of asthma", Clin. Exp. Allergy, 37, pp.498~505 (2007)
3. Miraglia del Giudice, M. Jr, "Probiotics and atopic dermatitis. A new strategy inatopic dermatitis", Dig. Liver Dis, 34(2), pp.S68~71 (2002)
4. Sheil, B., "Probiotic effects on inflammatory bowel disease", J. Nutr, 137(3), pp.819S~824S (2007)
5. Leung, D. Y., "New insights into atopic dermatitis", J. Clin. Invest, 113, pp.651~657 (2004)
6. Leung, D. Y., "New concepts in the pathogenesis of atopic dermatitis", Curr. Opin. Immunol, 15, pp.634~638 (2003)
7. Okada, H., "The'hygiene hypothesis' for autoimmune and allergic diseases: anupdate", Clin. Exp. Immunol, 160, pp.1~9 (2010)
8. Atherton, D. J., "Topical corticosteroids in atopic dermatitis", BMJ, 327, pp.942~943 (2003)
9. Jia, W., "Gut microbiota: a potential new territory for drug targeting", Nat. Rev. Drug Discov, 7, pp.123~129 (2008)
10. Bach, J. F, "The effect of infections on susceptibility to autoimmune and allergic diseases", N. Engl. J. Med, 347, pp.911~920 (2002)
11. Maggi, E, "The TH1", TH2 paradigm in allergy, 1998, pp.3, 233~244
12. Rautava, S., "The hygiene hypothesis of atopic disease-- an extended version", J. Pediatr. Gastroenterol. Nutr, 38, pp.378~388 (2004)
13. Shreiner, A., "“Microflora Hypothesis” of Allergic Disease, In GI Microbiotaand Regulation of the Immune System", pp.113~134 (2008), Springer
14. Turnbaugh, P. J., "The human microbiome project", Nature, 449, pp.804~810 (2007)
15. K. E. Nelson, "A catalog of reference genomes from the human microbiome", Science, 328, pp.994~999 (2010)
16. Tlaskalová-Hogenová, H., "The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases", Cell. Mol. Immunol, 8, pp.110~120 (2011)
17. Human Microbiome Project Consortium, "A framework for human microbiome research", Nature, 486, pp.215~221 (2012)
18. Cho, I., "The human microbiome: at the interface of health and disease", Nat. Rev. Genet, 13, pp.260~270 (2012)
19. Flohr, C, "Atopic dermatitis and the 'hygiene hypothesis': too clean to be true?", Br. J. Dermatol, 152, pp.202~216 (2005)
20. Gibbs, S., "Atopic dermatitis and the hygiene hypothesis: a case-control study", Int. J. Epidemiol, 33, pp.199~207 (2004)
21. Kalliomäki, M., "Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing", J. Allergy Clin. Immunol, 107, pp.129~134 (2001)
22. Penders, J., "Gut microbiota composition and development of atopic manifestations in infancy : the KOALA Birth Cohort Study. Gut 56 : 661-667", Gut, 56, pp.661~667 (2007)
23. Kendler, M., "Comparison of fecal microflora in children with atopiceczema", dermatitis syndrome according to IgE sensitization tofood, 2006, pp.17, 141~147
24. Ouwehand, A. C, "Antiallergic effects of probiotics", J. Nutr, 137(2), pp.794S~797S (2007)
25. Turnbaugh, P. J., "An obesity-associated gut microbiome with increased capacity for energy harvest", Nature, 444, pp.1027~1031 (2006)
26. Ley, R. E, "Microbial ecology: human gut microbes associated with obesity", Nature, 444, pp.1022~1023 (2006)
27. Million, M, "Obesity-associated gut microbiota is enriched in Lactobacillus reuteri and depleted in Bifidobacterium animalis and Methanobrevibacter smithii", Int. J. Obes., 36, pp.817~825 (2012)
28. Giongo, A., "Toward defining the autoimmune microbiome for type 1 diabetes", ISME J, 5, pp.82~91 (2011)
29. Ogden, N. S., "Probiotics: a complementary approach in the treatment and prevention of pediatric atopic disease", Curr. Opin. Allergy Clin. Immunol, 5, pp.179~184 (2005)
30. Guarner, F., "Gut flora in health and disease", Lancet, 361, pp.512~519 (2003)
31. Artis, D., "Epithelial-cell recognition ofcommensal bacteria and maintenance of immune homeostasis in the gut", Nat. Rev. Immunol, 8, pp.411~420 (2008)
32. Macdonald, T. T., "Immunity, inflammation, and allergy in the gut", Science, 307, pp.1920~1925 (2005)
33. Kelly, D., "Commensal gut bacteria: mechanisms of immune modulation", Trends Immunol, 26, pp.326~333 (2005)
34. Coombes, J. L., "Dendritic cells in intestinal immune regulation", Nat. Rev. Immunol, 8, pp.435~446 (2008)
35. Rescigno, M., "Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria", Nat. Immunol, 2, pp.361~367 (2001)
36. Mowat, A. M., "Anatomical basis of tolerance and immunity to intestinal antigens", Nat. Rev. Immunol, 3, pp.331~341 (2003)
37. O'Hara, A. M., "The gut flora as a forgotten organ", EMBO Rep, 7, pp.688~693 (2006)
38. Sudo, N., "The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction", J. Immunol, 159, pp.1739~1745 (1997)
39. Ostman, S., "Impaired regulatory T cell function in germ-free mice", Eur. J. Immunol, 36, pp.2336~2346 (2006)
40. Kong, H. H., "Skin microbiome: genomics-based insights into the diversity and role of skin microbes", Trends Mol. Med, 17, pp.320~328 (2011)
41. Grice, E. A., "Topographical and temporal diversity of the human skin microbiome", Science, 324, pp.1190~1192 (2009)
42. Gallo, R. L., "Microbial symbiosis with the innate immune defense system of the skin", J. Invest. Dermatol, 131, pp.1974~1980 (2011)
43. Kong, H. H., "Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis", Genome Res, 22, pp.850~859 (2012)
44. Lai, Y., "Commensal bacteria regulate Toll-like receptor 3-dependent inflammation after skin injury", Nat. Med, 15, pp.1377~1382 (2009)
45. Naik, S., "Compartmentalized control of skin immunity by resident commensals", Science, 377, pp.1115~1119 (2012)
46. Ouwehand, A. C., "Prebiotics and other microbial substrates for gut functionality", Curr. Opin. Biotechnol, 16, pp.212~217 (2005)
47. Adlerberth, I., "Mechanisms of Colonisation and Colonisation Resistance of the Digestive Tract Part 1: Bacteria", host Interactions, 2000, pp.2, 223~239
48. Fang, H., "Modulation of humoral immune response through probiotic intake", FEMS Immunol. Med. Microbiol, 29, pp.47~52 (2000)
49. Gill, H. S., "Enhancement of immunity in the elderly by dietary supplementationwith the probiotic Bifidobacterium lactis HN019.Am", J. Clin. Nutr, 74, pp.833~839 (2001)
50. Smits, H. H., "Selective probiotic bacteria induce IL-10-producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin", J. Allergy Clin. Immunol, 115, pp.1260~1267 (2005)
51. Ueno, N., "Heat-killed body of lactobacillus brevis SBC8803 ameliorates intestinal injury in a murine model of colitis by enhancing the intestinal barrier function", Inflamm. Bowel Dis, 17, pp.2235~2250 (2011)
52. Kwon, H. K., "Generation of regulatory dendritic cells and CD4+Foxp3+ T cells by probiotics administration suppresses immune disorders", Proc. Natl. Acad. Sci. U.S.A, 107, pp.2159~2164 (2012)
53. Winkler, P., "Molecular and cellular basis of microflora-hostinteractions", J. Nutr, 137(3), pp.756S~772S (2007)
54. Fink, L. N., "Human antigen-presenting cells respond differently togut-derived probiotic bacteria but mediate similar strain-dependentNK and T cell activation", FEMS Immunol. Med.Microbiol, 51, pp.535~546 (2007)
55. Young, S. L., "Bifidobacterial species differentially affect expression of cell surface markers and cytokines of dendritic cells harvested from cord blood", Clin. Diagn. Lab. Immunol, 11, pp.686~690 (2004)
56. Zeuthen, L. H., "Lactic acid bacteria inducing a weak interleukin-12 and tumor necrosis factor alpha response in human dendritic cells inhibit strongly stimulating lactic acid bacteria but act synergistically with gram-negative bacteria", Clin. Vaccine Immunol, 13, pp.365~375 (2006)
57. Homey, B., "Cytokines and chemokines orchestrate atopic skin inflammation", J. Allergy Clin. Immunol, 118, pp.178~189 (2006)
58. Vestergaard, C., "IL-10 augments the IFN-gamma and TNF-alpha induced TARC production in HaCaT cells: a possible mechanism in the inflammatory reaction of atopic dermatitis", J. Dermatol. Sci, 26, pp.46~54 (2001)
59. Konur, A., "Interferon (IFN)-gamma is a main mediator of keratinocyte (HaCaT) apoptosis and contributes to autocrine IFN-gamma and tumour necrosis factor-alpha production", Br. J. Dermatol, 152, pp.1134~1142 (2005)
60. Pivarcsi, A., "Chemokine networks in atopic dermatitis: traffic signals of disease", Curr. Allergy Asthma Rep, 5, pp.284~290
61. Trautmann, A., "T cell-mediated Fas-induced keratinocyte apoptosis plays a key pathogenetic role in eczematous dermatitis", J. Clin. Invest, 106, pp.25~35 (2000)
62. Kalliomäki, M., "Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial", Lancet, 357, pp.1076~1079 (2001)
63. Abrahamsson, T. R., "Probiotics in prevention of IgE-associated eczema: a double-blind, randomized, placebo-controlled trial", J. Allergy Clin. Immunol, 119, pp.1174~1180 (2007)
64. Wickens, K., "A differential effect of 2 probiotics in the prevention of eczema and atopy: a double-blind, randomized, placebo-controlled trial", J. Allergy Clin. Immunol, 122, pp.788~794 (2008)
65. Soh, S. E., "Probiotic supplementation in the first 6 months of life in at risk Asian infants--effects on eczema and atopic sensitization at the age of 1 year", Clin. Exp. Allergy, 39, pp.571~578 (2009)
66. Kopp, M. V., "Randomized, double-blind, placebo-controlled trial ofprobiotics forprimary prevention: no clinical effects ofLactobacillus GG supplementation", Pediatrics, 121, pp.e850~856 (2008)
67. Weston, S., "Effects of probiotics on atopic dermatitis: a randomisedcontrolled trial", Arch. Dis. Child, 90, pp.892~897 (2005)
68. Viljanen, M., "Probiotics in the treatment of atopic eczema", dermatitis syndrome in infants: a double-blind placebo-controlled trial, 2005, pp.60, 494~500
69. Sistek, D, "Is the effect of probiotics on atopic dermatitis confined to food sensitized children?", Clin. Exp. Allergy, 36, pp.629~633 (2006)
70. Fölster-Holst, R., "Prospective, randomized controlled trial on Lactobacillus rhamnosus in infants with moderate to severe atopic dermatitis", Br. J. Dermatol, 155, pp.1256~1261 (2006)
71. Chen, Y. S., "Randomized placebo-controlled trial of lactobacillus onasthmatic children with allergic rhinitis", Pediatr. Pulmonol, 45, pp.1111~1120 (2010)
72. Sawada, J., "Ingestion of heat-treated Lactobacillus rhamnosus GG prevents development of atopic dermatitis in NC", Nga mice, 2007, pp.37, 296~303
73. Tanaka, A., "Oral supplementation with Lactobacillus rhamnosus CGMCC 1.3724 prevents development of atopic dermatitis in NC", NgaTnd mice possibly by modulating local production of IFN-gamma, 2009, pp.18, 1022~1027
74. Won, T. J., "Oral administration of Lactobacillus strains from Kimchi inhibits atopic dermatitis in NC", Nga mice, 2011, pp.110, 1195~1202
75. Bouma, G, "The immunological and genetic basis of inflammatory bowel disease", Nat. Rev. Immunol, 3, pp.521~533 (2003)
76. Swidsinski, A., "Mucosal flora in inflammatory bowel disease", Gastroenterology, 122, pp.44~54 (2002)
77. Favier, C., "Fecal beta-D-galactosidase production and Bifidobacteria are decreased in Crohn's disease", Dig. Dis. Sci, 42, pp.817~822 (1997)
78. Gupta, P., "Is lactobacillus GG helpful in children with Crohn's disease?Results of a preliminary, open-label study", J. Pediatr.Gastroenterol. Nutr, 31, pp.453~457 (2000)
79. Kruis, W., "Maintenance of remission in ulcerative colitis is equally effective with Escherichia coli Nissle 1917 and with standard mesalamine", Gastroenterology, 120(5), pp.A127~ (2001)
80. Malchow, H. A., "Crohn's disease and Escherichia coli. A new approach in therapy to maintain remission of colonic Crohn's disease?", J. Clin. Gastroenterol, 25, pp.653~658 (1997)
81. Gionchetti, P, "Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo- controlled trial", Gastroenterology, 119, pp.305~309 (2000)
82. Venturi, A., "Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis", Aliment. Pharmacol. Ther, 13, pp.1103~1108 (1999)
83. O'Mahony, L., "Probiotic impact on microbial flora, inflammation and tumour development in IL-10 knockout mice", Aliment. Pharmacol. Ther, 15, pp.1219~1225 (2001)
84. Sheil, B., "Role of interleukin (IL-10) in probioticmediated immune modulation: an assessment in wild-type and IL-10 knock-out mice", Clin. Exp. Immunol, 144, pp.273~280 (2006)
85. Sheil, B., "Is the mucosal route of administration essential for probiotic function? Subcutaneous administration is associated with attenuation of murine colitis and arthritis", Gut, 53, pp.694~709 (2004)
86. Madsen, K. L, "Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice", Gastroenterology, 116, pp.1107~1114 (1999)
87. Schultz, M., "Lactobacillus plantarum 299V in the treatment and prevention of spontaneous colitis in interleukin-10-deficient mice", Inflamm. Bowel Dis, 8, pp.71~80 (2002)
88. Khoruts, A., "transplantation of the distal gut microbiota", Mucosal Immunol, 4, pp.4~7 (2011)
89. Delzenne, N. M., "Targeting gut microbiota in obesity: effects of prebiotics and probiotics", Nat. Rev. Endocrinol, 7, pp.639~646 (2011)

관련 논문AI추천